EA200870433A1 - Азагетероциклильные производные андростанов и андростенов в качестве лекарственных средств от сердечно-сосудистых расстройств - Google Patents
Азагетероциклильные производные андростанов и андростенов в качестве лекарственных средств от сердечно-сосудистых расстройствInfo
- Publication number
- EA200870433A1 EA200870433A1 EA200870433A EA200870433A EA200870433A1 EA 200870433 A1 EA200870433 A1 EA 200870433A1 EA 200870433 A EA200870433 A EA 200870433A EA 200870433 A EA200870433 A EA 200870433A EA 200870433 A1 EA200870433 A1 EA 200870433A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cardiovascular disorders
- azheterocyclylic
- androstenes
- androstanes
- medicine
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 150000001441 androstanes Chemical class 0.000 title 1
- 150000001443 androstenes Chemical class 0.000 title 1
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 2
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 201000006370 kidney failure Diseases 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- LPMXVESGRSUGHW-UHFFFAOYSA-N Acolongiflorosid K Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(CO)C(O)C1 LPMXVESGRSUGHW-UHFFFAOYSA-N 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- LPMXVESGRSUGHW-GHYGWZAOSA-N Ouabain Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)[C@H]1C[C@@H](O)[C@@]2(CO)[C@@](O)(C1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)C[C@@H](O)[C@H]21 LPMXVESGRSUGHW-GHYGWZAOSA-N 0.000 abstract 1
- 244000166550 Strophanthus gratus Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 230000001631 hypertensive effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 abstract 1
- 229960003343 ouabain Drugs 0.000 abstract 1
- 201000001474 proteinuria Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Соединения формулы (I), где группы имеют значения, определенные в описании изобретения, являются полезными для получения лекарственных средств для лечения сердечно-сосудистых расстройств, в частности сердечной недостаточности и гипертензии. Соединения являются ингибиторами ферментативной активности Na, K-АТФазы. Они являются полезными для получения лекарственного средства для лечения заболевания, вызванного гипертензивными эффектами эндогенного уабаина, такого как прогрессирование почечной недостаточности при аутосомальном доминантном поликистозном почечном заболевании (ADPKD), преэкламптической гипертензии и протеинурии и прогрессирование почечной недостаточности у пациентов с аддуциновым полиморфизмом.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06112605 | 2006-04-13 | ||
PCT/EP2007/053521 WO2007118830A1 (en) | 2006-04-13 | 2007-04-11 | Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200870433A1 true EA200870433A1 (ru) | 2009-04-28 |
EA015622B1 EA015622B1 (ru) | 2011-10-31 |
Family
ID=37309533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200870433A EA015622B1 (ru) | 2006-04-13 | 2007-04-11 | Азагетероциклильные производные андростанов и андростенов в качестве лекарственных средств от сердечно-сосудистых расстройств |
Country Status (16)
Country | Link |
---|---|
US (1) | US8536160B2 (ru) |
EP (1) | EP2004669B1 (ru) |
JP (1) | JP5438502B2 (ru) |
KR (1) | KR101411280B1 (ru) |
CN (1) | CN101466726B (ru) |
AU (1) | AU2007239516B2 (ru) |
BR (1) | BRPI0710613A2 (ru) |
CA (1) | CA2649173C (ru) |
EA (1) | EA015622B1 (ru) |
ES (1) | ES2403366T3 (ru) |
HK (1) | HK1134820A1 (ru) |
MX (1) | MX2008012943A (ru) |
PL (1) | PL2004669T3 (ru) |
PT (1) | PT2004669E (ru) |
TW (1) | TWI389917B (ru) |
WO (1) | WO2007118830A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA019929B1 (ru) | 2009-03-23 | 2014-07-30 | Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. | 5-β ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ |
WO2010149666A1 (en) | 2009-06-22 | 2010-12-29 | Medexis S.A. | Methods for treating neoplasia |
WO2012013816A1 (en) * | 2010-07-30 | 2012-02-02 | Medexis S.A. | Compounds and methods for treating neoplasia |
CN103304623B (zh) * | 2012-03-08 | 2015-05-20 | 华东师范大学 | 一种6β,19-环氧雄甾-3,17-二酮的合成方法 |
RU2766579C2 (ru) | 2015-07-02 | 2022-03-15 | ХОРАЙЗОН ОРФАН ЭлЭлСи | Цистеаминдиоксигеназа-резистентные аналоги цистеамина и их применение |
CN105237455A (zh) * | 2015-10-14 | 2016-01-13 | 湖南华腾制药有限公司 | 一种3-取代氮杂环丁烷的制备方法 |
CN108707180A (zh) * | 2018-08-08 | 2018-10-26 | 齐齐哈尔医学院 | 3β-羟基-5α,8α-过氧雄甾-6-烯-17-(靛红取代)腙衍生物及制备和应用 |
PL3805243T3 (pl) * | 2019-10-09 | 2024-03-18 | Windtree Therapeutics, Inc. | Pochodne androstanowe posiadające aktywność jako czyste lub w przeważającym stopniu czyste stymulatory SERCA2A do leczenia niewydolności serca |
CN113461771B (zh) * | 2020-03-31 | 2022-09-30 | 南方科技大学 | 钠钾atp酶抑制剂的制备方法 |
CN115850359A (zh) * | 2022-12-14 | 2023-03-28 | 梯尔希(南京)药物研发有限公司 | 一种孕二烯酮杂质i的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB868303A (en) * | 1956-09-08 | 1961-05-17 | Syntex Sa | New cyclopentanophenanthrene derivatives and process for the production thereof |
NL104586C (ru) | 1959-04-10 | |||
US3210386A (en) | 1961-01-09 | 1965-10-05 | Upjohn Co | 3-aminoethers of 3beta-hydroxy androstanes |
BE621470A (ru) * | 1961-08-17 | |||
GB1175219A (en) | 1967-06-22 | 1969-12-23 | Ici Ltd | 3-Aminoalkoxycarbonylmethylene Steroid Derivatives |
US5144017A (en) | 1988-07-13 | 1992-09-01 | University Of Manitoba | Compounds that bind to digitalis receptor |
DE19633349A1 (de) * | 1996-08-19 | 1998-02-26 | Sigma Tau Ind Farmaceuti | Neue 6-Hydroxy- und 6-Oxo-androstan-Derivate, die auf das kardiovaskuläre System wirken und pharmazeutische Zusammensetzungen, die diese enthalten |
US6100279A (en) | 1998-11-05 | 2000-08-08 | Schering Corporation | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
FR2826011B1 (fr) | 2001-06-14 | 2004-12-10 | Oreal | Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique |
FR2831440B1 (fr) | 2001-10-25 | 2003-12-26 | Oreal | Composition cosmetique, renfermant un derive de la dhea et un agent apaisant |
PL1689410T3 (pl) * | 2003-11-26 | 2008-10-31 | Bayer Schering Pharma Ag | Sposób zapobiegania i leczenia nadciśnieniowych chorób serca za pomocą selektywnych estrogenów: 8ß-winylo-estra-1,3,5(10)-trien-3,17ß-diolu i 17ß-fluoro-9a-winylo-estra-1,3,5(10)-trien-3,16a-diolu |
-
2007
- 2007-03-26 TW TW096110304A patent/TWI389917B/zh not_active IP Right Cessation
- 2007-04-11 US US12/296,532 patent/US8536160B2/en not_active Expired - Fee Related
- 2007-04-11 EA EA200870433A patent/EA015622B1/ru not_active IP Right Cessation
- 2007-04-11 AU AU2007239516A patent/AU2007239516B2/en not_active Ceased
- 2007-04-11 MX MX2008012943A patent/MX2008012943A/es active IP Right Grant
- 2007-04-11 PL PL07727989T patent/PL2004669T3/pl unknown
- 2007-04-11 PT PT77279891T patent/PT2004669E/pt unknown
- 2007-04-11 EP EP07727989A patent/EP2004669B1/en active Active
- 2007-04-11 WO PCT/EP2007/053521 patent/WO2007118830A1/en active Application Filing
- 2007-04-11 CA CA2649173A patent/CA2649173C/en not_active Expired - Fee Related
- 2007-04-11 CN CN200780022193.9A patent/CN101466726B/zh not_active Expired - Fee Related
- 2007-04-11 KR KR1020087027528A patent/KR101411280B1/ko not_active IP Right Cessation
- 2007-04-11 BR BRPI0710613-0A patent/BRPI0710613A2/pt active Search and Examination
- 2007-04-11 JP JP2009504740A patent/JP5438502B2/ja not_active Expired - Fee Related
- 2007-04-11 ES ES07727989T patent/ES2403366T3/es active Active
-
2009
- 2009-12-18 HK HK09111965.9A patent/HK1134820A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2649173C (en) | 2013-11-19 |
JP5438502B2 (ja) | 2014-03-12 |
US20090275542A1 (en) | 2009-11-05 |
US8536160B2 (en) | 2013-09-17 |
EA015622B1 (ru) | 2011-10-31 |
KR20080109916A (ko) | 2008-12-17 |
BRPI0710613A2 (pt) | 2011-08-16 |
AU2007239516A2 (en) | 2009-01-08 |
WO2007118830A1 (en) | 2007-10-25 |
TW200801032A (en) | 2008-01-01 |
AU2007239516A1 (en) | 2007-10-25 |
MX2008012943A (es) | 2008-10-15 |
KR101411280B1 (ko) | 2014-06-24 |
ES2403366T3 (es) | 2013-05-17 |
CN101466726A (zh) | 2009-06-24 |
CN101466726B (zh) | 2014-09-24 |
CA2649173A1 (en) | 2007-10-25 |
TWI389917B (zh) | 2013-03-21 |
JP2009533391A (ja) | 2009-09-17 |
PT2004669E (pt) | 2013-04-18 |
PL2004669T3 (pl) | 2013-06-28 |
EP2004669B1 (en) | 2013-01-23 |
HK1134820A1 (en) | 2010-05-14 |
AU2007239516B2 (en) | 2011-11-17 |
EP2004669A1 (en) | 2008-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200870433A1 (ru) | Азагетероциклильные производные андростанов и андростенов в качестве лекарственных средств от сердечно-сосудистых расстройств | |
EA201270666A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
NO20064489L (no) | Sulfaterte oligosakkarid derivater | |
EA200870434A1 (ru) | Аминопроизводные андростанов и андростенов как лекарственные средства против сердечно-сосудистых нарушений | |
EA200801997A1 (ru) | Новые соединения | |
ATE449097T1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer | |
ATE524450T1 (de) | 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren | |
NO20073790L (no) | Kjemiske forbindelser | |
NO20073788L (no) | Kjemiske forbindelser | |
DK2324008T3 (da) | Diarylpyrazol som protein kinase inhibitorer | |
ATE442349T1 (de) | Diacylglycerol-acyltransferase-hemmer | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
EA200970090A1 (ru) | Модуляторы метаболизма и лечение связанных с ним расстройств | |
MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
EA201071144A1 (ru) | Гетероциклические производные | |
DK2150530T3 (da) | Substituerede sulfonamid-derivater | |
WO2007123939A3 (en) | Novel arylamino n-heteraryls as mek inhibitors | |
BRPI0508177A (pt) | composto, processo para a produção do composto, composição farmacêutica, uso do composto método para o tratamento de uma doença e produto de combinação | |
WO2007146085A3 (en) | Creatine phosphate prodrugs, compositions and uses thereof | |
NO20063865L (no) | Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
MY150745A (en) | Isoserine derivatives for use as coagulation factor ixa inhibitors | |
NO20063859L (no) | Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter | |
NO20075637L (no) | 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet | |
CY1112012T1 (el) | Αμινουχα παραγωγα β-ομοανδροστανων και β-ετεροανδροστανων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |